Stock Research Monitor: ACHC, MD, and TVTY

LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want a free Stock Review on DVA sign up now at www.wallstequities.com/registration. Research reports have been issued by WallStEquities.com on: Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), MEDNAX Inc. (NYSE: MD), and Tivity Health Inc. (NASDAQ: TVTY). These stocks are part of the Specialized Health Services category, which includes companies that produce and distribute varying paper products to customers and businesses of all shapes and sizes. On average, the dividend yields of these firms tend to be slightly above the market average. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Acadia Healthcare

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s shares gained slightly by 0.05%, closing Tuesday's trading session at $41.58. The stock recorded a trading volume of 851,692 shares. The Company's shares have advanced 7.16% in the last month and 21.44% over the previous three months. The stock is trading 4.79% above its 50-day moving average and 6.50% above its 200-day moving average. Additionally, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities, have a Relative Strength Index (RSI) of 62.69.

On May 11th, 2018, Acadia Healthcare and Saint Thomas Health have entered into a joint venture to expand and improve access to behavioral health care in Nashville, Tennessee. The partnership will include the establishment of a new, 76-bed psychiatric inpatient hospital at Metro Center in Nashville, encompassing 40 adult psychiatric beds and 36 geriatric psychiatric beds. Get the full research report on ACHC for free by clicking below at:

www.wallstequities.com/registration/?symbol=ACHC

DaVita

On Tuesday, shares in Denver, Colorado headquartered DaVita Inc. recorded a trading volume of 1.21 million shares. The stock declined slightly by 0.47%, ending the day at $66.29. The Company's shares have advanced 4.94% in the past month and 0.39% over the past year. The stock is trading above its 50-day and 200-day moving averages by 0.84% and 2.25%, respectively. Furthermore, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 57.48.

On May 01st, 2018, DaVita Kidney Care, a division of DaVita, welcomed David Roer, M.D., as Vice President of medical affairs for VillageHealth, a subsidiary of the Company that specializes in integrated kidney care and renal population health management. Dr. Roer was also made a member of the Office of the Chief Medical Officer, the Company's physician leadership team. DVA's complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=DVA

MEDNAX

Sunrise, Florida-based MEDNAX Inc.'s stock finished the day 0.69% higher at $46.85 with a total trading volume of 834,771 shares. The stock is trading below their 200-day moving average by 4.60%. Shares of the Company, which together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 38.70.

On May 14th, 2018, MEDNAX announced that it is scheduled to present at the Bank of America Merrill Lynch 2018 Health Care Conference on May 17th, 2018, at 8:00 a.m. PT in Las Vegas. The presentation will be broadcast via a live audio webcast and will be available for replay on the Company's investors website. Register for your free research report on MD at:

www.wallstequities.com/registration/?symbol=MD

Tivity Health

Shares in Franklin, Tennessee headquartered Tivity Health Inc. ended yesterday's session 0.27% higher at $37.80. The stock recorded a trading volume of 459,981 shares. The Company's shares have advanced 0.13% over the previous three months and 14.37% over the past year. The stock is trading 1.38% below its 200-day moving average. Moreover, shares of Tivity Health, which provides fitness and health improvement programs in the US, have an RSI of 50.55.

On April 23rd, 2018, Tivity Health announced its results for Q1 ended March 31st, 2018. Revenues for the quarter were $149.9 million, net income was $21.3 million, and EBITDA was $33.1 million. Cash flow from operations for Q1 2018 was $12.4 million, and free cash flow totaled $10.4 million. Wall St. Equities' downloadable research report on TVTY available at:

www.wallstequities.com/registration/?symbol=TVTY

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities